Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.13 +0.21%   SPY: 134.79 +0.25%
Quote Spy AVII NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


AVI BioPharma (AVII)

@ 4:00 PM
Click the portfolio to add AVII:
Close [X]
+ Add AVII to Portfolio
  
  Last Trade: $1.11 +0.01 (0.91%)
  Volume: 1,455,855 213% of avg daily volume
       
  Avg Volume: 682,092
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 1.09 - 1.17
  Open: 1.14
  Previous Close: 1.10
  52-wk Range: 0.50 - 2.19
  Market Cap: 149.3M
  P/E: -13.8
  Div Yield: $0.00 (0.00%)
Indexes
Swine Flu and Bird F... (+0.4%)
Spy AVII

? Pro holders
? Member holders
? Items submitted
Additional AVII resources



Customize Links
To see which Pros and tickerspy members own AVII Sign up now
Latest AVII Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI BioPharma Announces Third Quarter 2011 Financial Results and Corporate Update Conference Call
AVII  
Linked by marketwire - October 26, 08:00AM from (www2.marketwire.com)
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, will report third quarter 2011 financial results  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI BioPharma Announces Second Quarter 2011 Financial Results and Corporate Update Conference Call
AVII  
Linked by marketwire - July 28, 08:00AM from (www2.marketwire.com)
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, will report second quarter 2011 financial results  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI BioPharma Announces First Quarter 2011 Financial Results
AVII  
Linked by marketwire - May 05, 04:00PM from (www2.marketwire.com)
AVI BioPharma, Inc. (NASDAQ: AVII)  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI BioPharma Announces First Quarter 2011 Financial Results and Corporate Update Conference Call
AVII  
Linked by marketwire - April 28, 08:00AM from (www2.marketwire.com)
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, will report first quarter 2011 financial results  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI BioPharma Names Peter S. Linsley, Ph.D., Chief Scientific Officer
AVII  
Linked by marketwire - March 28, 08:43AM from (www2.marketwire.com)
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, announced today the appointment of Peter S. Linsley,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI BioPharma Announces Fourth Quarter and Full Year 2010 Financial Results
AVII  
Linked by marketwire - March 10, 04:02PM from (www2.marketwire.com)
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today reported financial results for the three and 12  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI BioPharma Announces Fourth Quarter, Full Year 2010 Financial Results and Corporate Update Conference Call
AVII  
Linked by marketwire - March 03, 08:00AM from (www2.marketwire.com)
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, will report fourth quarter and full year 2010  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI Biopharma Names Effie Toshav Senior Vice President and General Counsel
AVII  
Linked by marketwire - January 07, 08:00AM from (www2.marketwire.com)
AVI BioPharma (NASDAQ: AVII) today announced the appointment of Effie Toshav, J.D., as senior vice president and general  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource